| Literature DB >> 32279921 |
Einars Loza1, Matthieu Sarciaux2, Martins Ikaunieks1, Martins Katkevics1, Tatyana Kukosha1, Nadezhda Trufilkina1, Victoria Ryabova1, Kirill Shubin1, Lucile Pantel2, Marine Serri2, Douglas L Huseby3, Sha Cao3, Kavita Yadav3, Karin Hjort3, Diarmaid Hughes3, Maxime Gualtieri2, Edgars Suna4, Emilie Racine5.
Abstract
A structure-activity relationship (SAR) study of NOSO-95179, a nonapeptide from the Odilorhabdin class of antibacterials, was performed by systematic variations of amino acids in positions 2 and 5 of the peptide. A series of non-proteinogenic amino acids was synthesized in high enantiomeric purity from Williams' chiral diphenyloxazinone by highly diastereoselective alkylation or by aldol-type reaction. NOSO-95179 analogues for SAR studies were prepared using solid-phase peptide synthesis. Inhibition of bacterial translation by each of the synthesized Odilorhabdin analogues was measured using an in vitro test. For the most efficient analogues, antibacterial efficacy was measured against two wild-type Enterobacteriaceae (Escherichia coli and Klebsiella pneumoniae) and against an efflux defective E. coli strain (ΔtolC) to evaluate the impact of efflux on the antibacterial activity.Entities:
Keywords: Inhibition of bacterial translation; Novel amino acids; Novel antibiotic class; Odilorhabdins; SAR
Mesh:
Substances:
Year: 2020 PMID: 32279921 DOI: 10.1016/j.bmc.2020.115469
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641